Multimedia
- Tutte le date
- Ultimi 12 mesi
- Ultimi 6 mesi
- Ultimi 3 mesi
28 progetti di trasformazione digitale finanziati nell’ambito del digital innovation hub IP4FVG, grazie al contributo di Area Science Park e del Piano di Sviluppo e Coesione della Regione Autonoma Friuli Venezia Giulia.
In seguito ai due bandi “Test4Digitalization”, i progetti selezionati hanno potuto sviluppare, in collaborazione con una o più imprese ICT nazionali o internazionali, prototipi, demo, proof of concept (POC) o iniziative pilota nate a partire da esigenze concrete di trasformazione digitale.
I progetti finanziati prevedono l’utilizzo di diverse tecnologie: dalla sensorizzazione all’automazione avanzata, dalla simulazione all’ottimizzazione, dall’AI all’integrazione dei processi, dal BIM al gaming.
Area Science Park con i suoi esperti in processi di trasferimento tecnologico e insieme ai 30 partner di IP4FVG ha fatto in questi anni una costante azione di informazione, formazione e affiancamento delle piccole e medie imprese del Friuli Venezia Giulia, attraverso l’analisi del loro livello di digitalizzazione, il supporto allo sviluppo di progetti di trasformazione digitale, lo scouting di tecnologie e di provider ICT, la dimostrazione delle tecnologie digitali in laboratori attrezzati.
Ce ne parla Monica Govetti, coordinatrice di IP4FVG.
Facilities for genomic and epigenomic research can be extremely useful in the fight against emerging diseases.
Scientists can identify the genes and proteins of infections by sequencing their genomes; these genes and proteins can subsequently be used as targets for vaccinations and medications.
Studies on the genome and epigenome can also help researchers better understand how pathogens change over time and adapt, which can be used to create ways to stop them from developing drug resistance.
This session describes the most current projects carried out by Area Science Park Genomics and Epigenomics lab.
Speaker: Danilo Licastro, Genomics and Epigenomics Laboratory (LAGE) – Area Science Park
All atom simulations allow uncovering the molecular mechanism of complex biological molecules, supporting and expanding experimental data.
In this talk I show how multiscale simulations can decipher the molecular mechanism of the (i) spliceosome, a complex protein/RNA macromolecular machinery, that removes noncoding introns from precursor messenger RNAs (pre-mRNAs) and ligates coding exons, giving rise to protein coding mRNAs and functional non-coding RNAs [1-3]; (ii) Ctr1 a transporter involved in Cu(I) internalization [4] and of (iii) the SARS-CoV-2 spike proteins and its variants of concerns as well as of the nsp1 protein [5-7].
Speaker: Alessandra Magistrato, SISSA – International School for Advanced Studies
The talk provides a brief introduction to epigenetics and epitranscriptomics, and gives a synthetic overview of the most significant RNA modifications discovered nowadays.
The aim of the talk is to inform the interested community of existing expertise at the Genomics and Epigenomics Lab, to stimulate proficient collaborations focused on the new viral epitranscriptomics field, which would add significant value to the Pathogen Readiness Platform project.
Speaker: Valentina Perrera, Area Science Park
The talk is about the sequencing using Oxford Nanopore technology (PromethION platform).
A brief summary of the advantages of nanopore based technology, is followed by the description of the major workflows for DNA and RNA seq.
Speaker: Margherita Degasperi, Genomics and Epigenomics Laboratory (LAGE) – Area Science Park
SISSI-Bio is the chemical and life science branch of the infrared beamline at Elettra.
In this presentation the most relevant features and instruments of SISSI-Bio will be introduced, focusing on the application of infrared vibrational spectroscopy on topics relevant for the PRP@CERIC project: IR cytology and IR histology for cell and tissue analysis, respectively.
The ultimate aim of the presentation is to introduce the audience to the approach for identifying common area of interest and synergic actions toward the PRP@CERIC goal.
Speaker: Lisa Vaccari, Elettra Sincrotrone Trieste
In this contribution, Ms. Rossi provides an overview of the basic principles of UV resonance Raman spectroscopy and its possible applications in the investigation of biological specimens.
A description is provided of the advantages and challenges of this technique, representing a unique label-free tool for non-invasive study of nucleic acids, proteins, organic samples and pathogens.
The portfolio of the multi-wavelengths UV Raman setups available on the IUVS beamline at Elettra Sincrotrone is presented.
Special focus is given to the instrumental upgrades planned in the framework of PRP@Ceric and Elettra 2.0.
Speaker: Barbara Rossi, Elettra Sincrotrone Trieste
The seminar presents the application of an integrative structural biology approach to the field of neurotrophins.
The interaction of ATP with both mature NGF and its precursor was investigated with solution NMR and a set of complementary biophysical and computational methodologies.
The used methods are briefly presented, as well as the scientific results.
From these data, it was possible to identify the role of ATP in modulating the neurotrophin biology and this can explain some features of neurodegeneration.
Speaker: Francesca Paoletti, Institute of Crystallography – CNR
Artificial Cell membrane mimetic platforms to assess extracellular vesicles/pathogens-cell interaction.
Speaker: Loredana Casalis, Elettra Sincrotrone Trieste
In casi di specifiche patologie particolari, come alcune forme di epilessia, la dieta chetogenica può essere utilizzata come terapia nutrizionale.
Questo particolare regime alimentare è però difficile da seguire, specialmente per i bambini, a causa della drastica riduzione dei carboidrati e dell’alto livello di grassi.
Per questo il Dr. Schär R&D Centre, partendo dagli studi clinici e con l’ausilio delle tecnologie, sviluppa nuovi prodotti per la dieta chetogenica, con grande attenzione alle materie prime.
Ne abbiamo parlato con Ombretta Polenghi, Head of Research & Innovation del Dr. Schär R&D Centre, e Fabio Barban, Director of Product Development Medical Nutrition del Dr. Schär R&D Centre.
Over the last 20 years the emphasis in structural biology has shifted from the technique (crystallography, NMR, etc..) to biological issues.
Due to a number of technical advances in both biology and structural analysis, the size and complexity of the macromolecular targets have systematically increased.
In a number of cases, this has required the combination of multiple techniques, to be used in an integrated approach, to fully understand the structure, function and dynamics of the biological complex.
This is particularly true for protein-nucleic acid complexes, which often show a degree of polymorphism, multiple conformations, presence of disordered regions, a multiplicity of alternative substrates, and so on.
Mrs. Onesti’s research is focused on a number of proteins involved in basic genetic processes, including DNA replication, DNA repair, transcription and translation.
In particular, she has focused on helicases, which are molecular motors able to unwind a variety of nucleic acid substrates (DNA, RNA, G-quadruplexes, R-loops, etc..); being essential in nucleic acid metabolism they are becoming novel targets for anti-viral, anti-bacterial and anti-tumor drugs.
The talk covers some of the recent projects, focusing on the use of a combination of macromolecular crystallography and single particle electron microscopy to understand the structure and function of a number of DNA and RNA helicases involved in replication and repair, and thus involved in genetic diseases, cancer development and progression and aging.
Speaker: Silvia Onesti, Elettra Sincrotrone Trieste
Prevention of virus infection can be performed following different strategies, from the development of effective vaccines to the reduction of the vector in the case of insects-borne viral infection.
All these strategies rely on a deep knowledge of the biology of the virus.
For instance, development of new vaccines requires the characterization of the structure that the viral proteins assume during the different steps of the viral cycle.
Also, antiviral molecules can be used not only as a cure but also as prevention tools when directly expressed in insect vectors.
Speaker: Giuditta De Lorenzo, RIT – Area Science Park